JPRN-UMIN000007632已完成4 期
Evaluation of third-line eradication for H. pylori infection in Japan - Third-line eradication of H. pylori
Japan Gast Study Group0 个研究点目标入组 150 人开始时间: 2012年4月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
The highest eradication rate was 70% in PPI based one-week triple therapy using AMPC and STFX.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •a history of antimicrobials after 2nd-line eradcation a history of PPI use 1 week before entry a history of NSAID or steriod use 1 month before entry a history of gastrointestinal surgery, the severe liver, renal, and cardiopulmonary dysfunctions a history of drug allergy
研究者
相似试验
已完成
不适用
Efficacy of triple therapy for Helicobacter pylori infection using amoxicillin and clarithromycin and TAK-438 (vonoprazan) which is a novel potassium-competitive acid blocker to the patients treated unsuccessfully with PPI, amoxicillin and clarithromycin.Chronic gastritisJPRN-UMIN000017891Kagawa Prefectural Central Hospital150
已完成
2 期
Third-line H. pylori eradication therapy with sitafloxacin-including regimePatients with H. pylori eradication failure after the second-line regimenJPRN-UMIN000001558DIvision of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine30
已完成
不适用
The efficacy of third or fourth line H. pylori eradication therapy with refabutin-amoxicillin-vonaprazan 7day regimeH. pylori-positve patients after the 2nd line eradication failureJPRN-UMIN000021928Keio University School of Medicine66
已完成
不适用
Analysis of third-line H. pylori eradication therapy with sitafloxaciPatients with H. pylori eradication failure after first- and second-line therapyJPRN-UMIN000001902Department of Gastroenterology, University of Tokyo50
已完成
3 期
Third line H. pylori eradication therapy with sitafloxacin, amoxicillin and vonaprazaJPRN-UMIN000022235Keio University School of Medicine114